Literature DB >> 15314126

Mechanical ventilation and tracheostomy in multiple sclerosis.

S J Pittock1, B G Weinshenker, E F M Wijdicks.   

Abstract

Decisions on ventilatory support (VS) in multiple sclerosis (MS) are complex. All patients with MS requiring mechanical ventilation or tracheostomy since 1969 (22) at Mayo Clinic were reviewed. Seventeen had progressive (PMS; 11 secondary and six primary progressive) and one had relapsing remitting MS (RRMS). Four had neuromyelitis optica (NMO). Of those with PMS, all but two required a wheelchair or were bedbound before VS and survived a median of 22 months; 14 were mechanically ventilated and seven underwent subsequent lifelong tracheostomy; three had tracheostomy only. The indications (usually multiple) for VS in PMS patients were aspiration pneumonia, poor ventilation because of mucous plugging, mechanical failure, and airway control/protection for seizures and coma. The RRMS patient required mechanical ventilation for 10 days, with subsequent short-term tracheostomy during a brainstem exacerbation. Of the four patients with NMO one made a dramatic recovery after plasmapheresis. Compared with PMS, the NMO group had a shorter time from disease onset to VS, a longer duration of ventilation, and the three patients not treated with plasma exchange or steroids did worse. The prognosis for independent ventilation (+/- tracheostomy) was worst for patients with NMO, except for one patient who received plasma exchange, and better then expected for PMS, despite poor preventilation functional status.

Entities:  

Mesh:

Year:  2004        PMID: 15314126      PMCID: PMC1739232          DOI: 10.1136/jnnp.2003.024257

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  4 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Intensive care unit admission in multiple sclerosis: increased incidence and increased mortality.

Authors:  Ruth Ann Marrie; Charles N Bernstein; Christine A Peschken; Carol A Hitchon; Hui Chen; Randy Fransoo; Allan Garland
Journal:  Neurology       Date:  2014-05-07       Impact factor: 9.910

3.  Cervical spinal demyelination with ethidium bromide impairs respiratory (phrenic) activity and forelimb motor behavior in rats.

Authors:  N L Nichols; A M Punzo; I D Duncan; G S Mitchell; R A Johnson
Journal:  Neuroscience       Date:  2012-11-14       Impact factor: 3.590

4.  CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies.

Authors:  Hannah H Zhao-Fleming; Cristina Valencia Sanchez; Elia Sechi; Jery Inbarasu; Eelco F Wijdicks; Sean J Pittock; John J Chen; Dean M Wingerchuk; Brian G Weinshenker; Sebastian Lopez-Chiriboga; Divyanshu Dubey; Jan-Mendelt Tillema; Michel Toledano; Hemang Yadav; Eoin P Flanagan
Journal:  Neurology       Date:  2021-08-13       Impact factor: 9.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.